IMP脱氢酶
肌苷
生物化学
肌苷酸
化学
幽门螺杆菌
酶
结核分枝杆菌
脱氢酶
药理学
IC50型
生物合成
核苷酸
体外
生物
肺结核
医学
霉酚酸
移植
病理
外科
基因
遗传学
作者
Niteshkumar U. Sahu,Gayathri Purushothaman,Vijay Thiruvenkatam,Prashant S. Kharkar
摘要
Inosine 5′‐monophosphate dehydrogenase (IMPDH) catalyzes a crucial step in the biosynthesis of guanine nucleotides. Being a validated target for immunosuppressive, antiviral, and anticancer drug development, lately it has been exploited as a promising target for antimicrobial therapy. Extending our previous work on Mycobacterium tuberculosis IMPDH, GuaB2, inhibitor development, we screened a set of 23 new chemical entities (NCEs) with substituted flavone (Series 1) and 1,2,3‐triazole (Series 2) core structures for their in vitro Helicobacter pylori IMPDH (HpIMPDH) and human IMPDH2 (hIMPDH2) inhibitory activities. All the NCEs possessed acceptable molecular, physicochemical, and toxicity property profiles. The ranges for HpIMPDH and hIMPDH2 inhibition were 9–99.9% and 16–57%, respectively, at 10 μM concentration. The most potent HpIMPDH inhibitor, 25c, exhibited IC50 value of 1.27 μM with no hIMPDH2 inhibitory activity. The moderately potent, structurally novel hit molecule, 25c, may serve as a lead for further design and development of highly potent HpIMPDH inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI